European equities traded in the US as American depositary receipts kicked off the week tracking lower late Monday morning, declining 0.70% to 1,878.28 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and consumer goods company Unilever (UL), which advanced 1.6% and 1.1% respectively. They were followed by biotech firm BioNTech (BNTX) and brewing company Anheuser-Busch InBev (BUD), which increased 0.9% and 0.8% respectively.
The decliners from continental Europe were led by biopharmaceutical companies Cellectis (CLLS) and DBV Technologies (DBVT), which dropped 9.1% and 3.8% respectively. They were followed by petroleum refiner Equinor (EQNR) and telecommunications company Nokia (NOK), which lost 3.5% each.
The gainers from the UK were led by pharmaceutical company GSK (GSK) and tobacco company British American Tobacco (BTI), which rose 1.5% and 1.4% respectively. They were followed by pharmaceutical company AstraZeneca (AZN) and hospitality company InterContinental Hotels Group (IHG), which were up 1.3% and 0.8% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Bicycle Therapeutics (BCYC), which fell 4.1% and 3.7% respectively. They were followed by biopharmaceutical company NuCana (NCNA) and mining company BHP Group (BHP), which were down 3.5% and 3.3% respectively.
Comments